Bridgeway Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bridgeway Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$837K	Sell	18,000 -30,000	-63%	-$1.44M	0.01%	768
2026 Q1	$2.48M	Sell	48,000 -10,000	-17%	-$509K	0.05%	469
2025 Q4	$2.88M	Sell	58,000 -35,600	-38%	-$1.73M	0.06%	405
2025 Q3	$4.47M	Sell	93,600 -28,300	-23%	-$1.14M	0.1%	274
2025 Q2	$3.84M	Buy	121,900 +55,500	+84%	+$1.78M	0.09%	304
2025 Q1	$2.17M	Buy	+66,400	New	+$2.35M	0.05%	473
2019 Q2	–	Sell	-14,800	Closed	-$519K	–	1388
2019 Q1	$519K	Hold	14,800	–	–	0.01%	1013
2018 Q4	$492K	Hold	14,800	–	–	0.01%	1009
2018 Q3	$745K	Hold	14,800	–	–	0.01%	1018
2018 Q2	$886K	Hold	14,800	–	–	0.01%	915
2018 Q1	$678K	Sell	14,800 -700	-5%	-$29.2K	0.01%	990
2017 Q4	$618K	Buy	15,500 +50	+0.3%	+$1.98K	0.01%	1026
2017 Q3	$618K	Sell	15,450 -1,500	-9%	-$64.9K	0.01%	1030
2017 Q2	$731K	Buy	16,950 +50	+0.3%	+$1.78K	0.01%	957
2017 Q1	$529K	Buy	16,900 +5,800	+52%	+$155K	0.01%	1054
2016 Q4	$280K	Buy	+11,100	New	+$248K	﹤0.01%	1239
2015 Q2	–	Sell	-50,000	Closed	-$605K	–	1529
2015 Q1	$605K	Hold	50,000	–	–	0.01%	1002
2014 Q4	$415K	Sell	50,000 -550	-1%	-$4.62K	0.01%	1130
2014 Q3	$439K	Buy	50,550 +550	+1%	+$4.97K	0.01%	1138
2014 Q2	$548K	Hold	50,000	–	–	0.01%	1036
2014 Q1	$447K	Hold	50,000	–	–	0.01%	1128
2013 Q4	$377K	Hold	50,000	–	–	0.01%	1162
2013 Q3	$367K	Hold	50,000	–	–	0.01%	1161
2013 Q2	$322K	Buy	+50,000	New	+$294K	0.01%	1141

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Bridgeway Capital Management's SUPN Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Supernus Pharmaceuticals (SUPN) stake by 63% in Q2 2026, selling an estimated $1.44M and leaving 18,000 shares worth $837K. The position accounts for 0.01% of the portfolio, ranked #768.

Bridgeway Capital Management first reported a position in SUPN in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.47M in Q3 2025. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Bridgeway Capital Management held 18,000 shares of Supernus Pharmaceuticals worth $837K as of Q2 2026.
Bridgeway Capital Management sold 30,000 Supernus Pharmaceuticals shares in Q2 2026, an estimated $1.44M.
Supernus Pharmaceuticals made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #768 holding.
Bridgeway Capital Management first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
Bridgeway Capital Management's Supernus Pharmaceuticals position peaked at $4.47M in Q3 2025.
335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.